top 4 questions is all I need
top 4 questions is all I need . For this scenario: Using the information provided, determine if the results indicate an obstructive, restrictive, or mixed pattern of deficit. Determine whether the pattern is reversible or non-reversible. Grade the severity of the disorder using the GOLD guidelines as appropriate. Provide the most likely diagnosis for the client. For each client, list one treatment strategy including rationale https://goldcopd.org/2022-gold-reports-2/ https://ginasthma.org/gina-reports/ Patient Scenario 2 You are assigned to the mobile clinic today to provide services for the local senior apartment complex in a rural area. Jensen Walton, 67-year-old male is the first to arrive at the clinic. During the HPI, Jensen said he was concerned about being diagnosed with 2 upper respiratory infections (URI) in the past 7 months. Since the second URI, Jensen felt fatigued. He was employed at the water treatment plant for 42 years. He retired 2 months ago. Post spirometry results Test Result (% Predicted) % Change FEV1/FVC 62 3 FEV1 49 6 FVC 48 6 please, use these articles: https://goldcopd.org/2022-gold-reports-2/ https://ginasthma.org/gina-reports/ Scholarly U.S. Provider (NP, PA, MD, DO) Journal Articles /COPD 1: Interpretation of results Q2: Interpretation of reversibility/GOLD severity grading Q3 : Most likely diagnosis Q4: Treatment strategy with rationale The lower questions were already . I just need help on the questions on very top Explanation: Q1. The hallmark of COPD is airflow obstruction. Pulmonary function testing. It shows airflow obstruction with a reduction in FEV1 and FEV1/FVC. Q2. GOLD 1: Mild FEV1 > 80% predicted GOLD 2: Moderate FEV1 50 to < 80% predicted GOLD 3: Severe FEV1 30 to < 50% predicted GOLD 4: Very severe FEV1 < 30 predicted Q3 : COPD severe because of FEV1 <50% Q4: Smoking cessation (the most important) LAMA examples are aclidinium (Genuair), glycopyrronium (Breezhaler), tiotropium (HandiHaler, Respimat) and umeclidinium (Ellipta). Work by preventing acetylcholine's bronchoconstriction action by preventing the neurotransmitter's ability to tighten the muscles that surround the lungs' airways, this lessens the symptoms of COPD. Additionally, compared to LABA, it demonstrated a much-decreased incidence of all unfavorable outcomes. SCIENCE HEALTH SCIENCE NURSING NURSING NR 601
******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."
